Concentration of prion protein from biological samples to increase the limits of detection by immunoassay

被引:7
作者
Davidowitz, E
Eljuga, L
Dover, K
Tian, J
Grossman, A
机构
[1] Q RNA Inc, New York, NY 10032 USA
[2] Ft Dodge Anim Hlth, Div Wyeth, Mitake, Tokyo 50501, Japan
关键词
ante- and post-mortem tests for prions; brain homogenate; proteirase K; RNA ligand;
D O I
10.1042/BA20040080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An RNA-ligand-based adsorbent has been shown to concentrate prion protein (PrP) from solutions in a model system. The work presented here extends the utility of the RNA-based adsorbent to brain homogenates of cow, sheep, mule deer (Odocoileus hemionus) and elk (Cervus elaphus). Brain homogenates were diluted either in buffer, representing specimens used in post-mortem tests, or in serum, modelling specimens used in biological-fluid-based tests. The RNA adsorbent was effective in binding PrPC (cellular PrP,) and PrPres (proteinase K-resistant PrP) from the brain homogenates of all the species tested in both model systems. The three antibodies against PrP used in the experiments identified PrP in immunoblot analysis after concentrating PrP from brain homogenates with the adsorbent, indicating the general applicability of this technology for improving the detection of PrP in immunoassays. Utilization of RNA adsorbent increased the level of detection of Prp(res) by immunoblot over several-hundredfold. The results obtained suggest that this RNA adsorbent can be used to increase detection in current post-mortem immunoassays and for the development of a blood-based ante-mortern test.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 21 条
[1]   Small, highly structured RNAs participate in the conversion of human recombinant PrpSen to PrpRes in vitro [J].
Adler, V ;
Zeller, B ;
Kryukov, V ;
Kascsak, R ;
Rubenstein, R ;
Grossman, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 332 (01) :47-57
[2]   Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease [J].
Cervenakova, L ;
Brown, P ;
Soukharev, S ;
Yakovleva, O ;
Diringer, H ;
Saenko, EL ;
Drohan, WN .
ELECTROPHORESIS, 2003, 24 (05) :853-859
[3]   Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein [J].
Giaccone, G ;
Canciani, B ;
Puoti, G ;
Rossi, G ;
Goffredo, D ;
Iussich, S ;
Fociani, P ;
Tagliavini, F ;
Bugiani, O .
BRAIN PATHOLOGY, 2000, 10 (01) :31-37
[4]  
Ironside JW, 2004, CURR TOP MICROBIOL, V284, P133
[5]   Variant Creutzfeldt-Jakob disease and its transmission by blood [J].
Ironside, JW ;
Head, MW .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1479-1486
[6]   Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence [J].
Jackman, R ;
Schmerr, MJ .
ELECTROPHORESIS, 2003, 24 (05) :892-896
[7]   Prion (PrPSc)-specific epitope defined by a monoclonal antibody [J].
Korth, C ;
Stierli, B ;
Streit, P ;
Moser, M ;
Schaller, O ;
Fischer, R ;
SchulzSchaeffer, W ;
Kretzschmar, H ;
Raeber, A ;
Braun, U ;
Ehrensperger, F ;
Hornemann, S ;
Glockshuber, R ;
Riek, R ;
Billeter, M ;
Wuthrich, K ;
Oesch, B .
NATURE, 1997, 390 (6655) :74-77
[8]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[9]   Polymeric ligands with specificity for aggregated prion proteins [J].
Lane, A ;
Stanley, CJ ;
Dealler, S ;
Wilson, SM .
CLINICAL CHEMISTRY, 2003, 49 (10) :1774-1775
[10]   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion [J].
Llewelyn, CA ;
Hewitt, PE ;
Knight, RSG ;
Amar, K ;
Cousens, S ;
Mackenzie, J ;
Will, RG .
LANCET, 2004, 363 (9407) :417-421